After revolutionizing weight loss, GLP-1s show promise on another front: opioid addiction - The Globe and Mail

Researchers test whether drugs to reduce food cravings can help people with substance-use disorders, but urge a cautious approach

Adam Scioli gets excited when he speaks about GLP-1 medications. Not because they’re known globally for revolutionizing weight-loss management, but because he thinks this class of drugs is the next frontier of addictions treatment. Dr. Scioli helped to transform care at Caron Treatment Centers in the United States during his recent tenure at the elite non-profit as an addictions psychiatrist and chief medical officer. Caron is believed to be the first of very few rehabilitation facilities in the world that prescribe GLP-1s off-label to treat substance-use disorders. Open this photo in…

saved by

• ami b

related reading

• Why Does Ozempic Cure All Diseases?astralcodexten.com
• If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?derekthompson.org
• The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
• Introducing GLP-1 Insightsouraring.com
• Psychedelics Could Play A Role In Tackling The Opioid Epidemic | HuffPost Lifehuffpost.com
• The Degradation Drug - The American Scholartheamericanscholar.org
• Semaglutide & Its Friendspanpharmacon.substack.com
• Consumers’ Expectations about GLP-1 Drugs Economic Impact on Food System Players - farmdoc dailyfarmdocdaily.illinois.edu
• GLP-1 drug use cuts grocery spending by 6%, study findsfooddive.com
• The Degradation Drug - The American Scholartheamericanscholar.org
• American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists | American Society of Anesthesiologists (ASA)asahq.org
• Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharmacheekypint.substack.com